Previous 10 | Next 10 |
Gainers: Eltek (NASDAQ: ELTK ) +373% . Valeritas Holdings (NASDAQ: VLRX ) +40% . Soliton (NASDAQ: SOLY ) +34% . Technical Communications Corporation (NASDAQ: TCCO ) +30% . ReWalk Robotics (NASDAQ: RWLK ) +28% . Netshoes (Cayman) Limited (NYSE: NETS ) +19% . Cara Therapeutics (N...
Gainers: Avianca Holdings (NYSE: AVH ) +29% . Outlook Therapeutics (NASDAQ: OTLK ) +28% . Hibbett Sports (NASDAQ: HIBB ) +21% . Total System Services (NYSE: TSS ) +16% . Cavco Industries (NASDAQ: CVCO ) +16% . Biocept (NASDAQ: BIOC ) +13% . DASAN Zhone Solutions (NASDAQ: DZSI )...
Immuron (NASDAQ: IMRN ) has priced its public offering of 500K American Depositary Shares ((ADSs)) at $4.00 per ADS, for gross proceeds of $2M. More news on: Immuron Limited, Healthcare stocks news, Read more ...
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced the pricing of an ...
Australia's Immuron (NASDAQ: IMRN ) has announced a public offering of its American Depositary Shares . More news on: Immuron Limited, Healthcare stocks news, Global news and forex, Read more ...
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced that it intends to ...
MELBOURNE, Australia, April 30, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immuno-therapeutics for the treatment of gut mediated diseases, today announced that CEO Dr. Gary S. Jaco...
MELBOURNE, Australia, April 17, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced the appointment o...
Sector Technicals Last week, the XBI (SPDR Biotech ETF) and IBB (iShares Nasdaq Biotechnology ETF) fell 4.16% and 3.38%, respectively. When markets have a tough week, take advantage of this opportunity to scan for stocks that are swimming upstream against the tide. Data by YCharts ...
Key Highlights: Immuron achieved 66% YoY growth in worldwide sales for the third quarter of FY19, ending March 31, 2019. In Australia Q3 sales of Travelan® surged ahead, growing 73% YoY. In the US Q3 sales of Travelan® were similarly strong, growing 60% YoY. During Q3 F...
News, Short Squeeze, Breakout and More Instantly...
Immuron Limited Company Name:
IMRN Stock Symbol:
NASDAQ Market:
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated bio...
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive Director effective today to focus on his other bu...
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated b...